0001555280-22-000217.txt : 20220725 0001555280-22-000217.hdr.sgml : 20220725 20220725160850 ACCESSION NUMBER: 0001555280-22-000217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220721 FILED AS OF DATE: 20220725 DATE AS OF CHANGE: 20220725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PECK KRISTIN C CENTRAL INDEX KEY: 0001488267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 221103421 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_165877971671145.xml FORM 4 X0306 4 2022-07-21 0 0001555280 Zoetis Inc. ZTS 0001488267 PECK KRISTIN C C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 Chief Executive Officer Common Stock 2022-07-21 4 M 0 4725 30.89 A 44468 D Common Stock 2022-07-21 4 M 0 4964 41.83 A 49432 D Common Stock 2022-07-21 4 S 0 9689 180 D 39743 D Stock Option 2022-07-21 4 M 0 4725 0 D Common Stock 4725.0 326978 D Stock Option 2022-07-21 4 M 0 4964 0 D Common Stock 4964.0 322014 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 4,725 options granted March 4, 2014 at an exercise price of $30.89 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. 4,964 options granted February 19, 2016 at an exercise price of $41.83 per option. 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,250 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. /s/ Brenda Santuccio, as Attorney-in-Fact 2022-07-25